Evaluation of the Safety and Efficacy of an Injectable Liposomal Gel (NCT06997380) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of the Safety and Efficacy of an Injectable Liposomal Gel
Poland36 participantsStarted 2025-05-23
Plain-language summary
The aim of this study is to evaluate the efficacy and safety of intradermal injections of the medical device - hyaluronic acid with the addition of lecithin - in a population of participants with thin, dry, and sagging facial skin.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Female sex;
✓. Age over 18 years;
✓. Caucasian race;
✓. Thin, dry, and sagging facial skin;
✓. Signing an informed consent form;
✓. Commitment to refrain from undergoing facial therapies that may affect skin condition;
✓. Negative pregnancy test result and commitment to use a contraceptve method;
Exclusion criteria
✕. Scars, birthmarks, or tattoos on the face that could interfere with the assessment of skin condition;
✕. Presence of open wounds, ulcers, active infections, or other significant skin damage at the planned injection site;
✕. Receipt of intradermal facial injections with native hyaluronic acid, platelet-rich plasma, or other injectable therapies within 6 months prior to study initiation;
✕. Receipt of intradermal facial injections with slowly absorbable or non-absorbable filler products within 12 months prior to study initiation;
✕. Known hypersensitivity to any component of the investigational product;
✕. Dermatitis or dermatological disease of inflammatory and/or infectious nature at the planned injection site;
What they're measuring
1
Change in facial skin thickness
Timeframe: No later than 8 weeks after the last injection